Menu
Annual · values2025202420232022
Operating Cash Flow-1.89 M USD-3.92 M USD-2.85 M USD-2.24 M USD
Depreciation & Amortization1.15 M USD1.12 M USD1.12 M USD1.11 M USD
Stock-Based Compensation13000 USD19000 USD
Capital Expenditures
Cash Flow from Investing3000 USD2000 USD-15000 USD-349000 USD
Cash Flow from Financing-109000 USD5.92 M USD2.87 M USD2.55 M USD
Dividends Paid
Stock Buybacks
Free Cash Flow

Impact Biomedical Inc. is a pioneering company within the biotechnology sector, focused on developing innovative solutions that address key challenges in health and wellness. The primary function of Impact Biomedical Inc. is to research and create cutting-edge biotechnologies that have the potential to significantly impact pharmaceuticals, cosmetics, and other health-related industries. Notable features of the company include its strong emphasis on developing anti-pathogenic compounds, next-generation health supplements, and immunotherapy treatments. Impact Biomedical collaborates with research institutions and global partners to leverage scientific advancements and bring novel products to the market. As a player in the biotech market, Impact Biomedical Inc. plays a crucial role in advancing medical science and providing tools that combat health threats, contributing to the overall development and enhancement of public health solutions. Its innovations are particularly significant as they promise improvements in treatment efficacy and accessibility, thereby influencing various sectors aligned with health and disease prevention.